155 related articles for article (PubMed ID: 1401173)
1. Expression of Ki-67 nuclear antigen in B and T cell lymphoproliferative disorders.
de Melo N; Matutes E; Cordone I; Morilla R; Catovksy D
J Clin Pathol; 1992 Aug; 45(8):660-3. PubMed ID: 1401173
[TBL] [Abstract][Full Text] [Related]
2. Expression of the CD11c antigen in B-cell chronic lymphoproliferative disorders.
Marotta G; Raspadori D; Sestigiani C; Scalia G; Bigazzi C; Lauria F
Leuk Lymphoma; 2000 Mar; 37(1-2):145-9. PubMed ID: 10721778
[TBL] [Abstract][Full Text] [Related]
3. Correlation of transferrin receptor expression with histologic grade and immunophenotype in chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
Das Gupta A; Shah VI
Hematol Pathol; 1990; 4(1):37-41. PubMed ID: 2187855
[TBL] [Abstract][Full Text] [Related]
4. Three new monoclonal antibodies that define a unique antigen associated with prolymphocytic leukemia/non-Hodgkin's lymphoma and are effectively internalized after binding to the cell surface antigen.
Okazaki M; Luo Y; Han T; Yoshida M; Seon BK
Blood; 1993 Jan; 81(1):84-94. PubMed ID: 8417805
[TBL] [Abstract][Full Text] [Related]
5. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.
Bennett JM; Catovsky D; Daniel MT; Flandrin G; Galton DA; Gralnick HR; Sultan C
J Clin Pathol; 1989 Jun; 42(6):567-84. PubMed ID: 2738163
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity.
Cordone I; Matutes E; Catovsky D
Leukemia; 1992 Sep; 6(9):902-6. PubMed ID: 1387694
[TBL] [Abstract][Full Text] [Related]
7. [Non-Hodgkin's lymphoma. Cytology and cytochemistry].
Schwarze EW
Veroff Pathol; 1986; 123():1-241. PubMed ID: 3518274
[TBL] [Abstract][Full Text] [Related]
8. Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
Palanca-Wessels MC; Czuczman M; Salles G; Assouline S; Sehn LH; Flinn I; Patel MR; Sangha R; Hagenbeek A; Advani R; Tilly H; Casasnovas O; Press OW; Yalamanchili S; Kahn R; Dere RC; Lu D; Jones S; Jones C; Chu YW; Morschhauser F
Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619
[TBL] [Abstract][Full Text] [Related]
9. Chronic lymphoproliferative disorders: classification and diagnosis.
Litz CE; Brunning RD
Baillieres Clin Haematol; 1993 Dec; 6(4):767-83. PubMed ID: 8038489
[TBL] [Abstract][Full Text] [Related]
10. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].
Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F
Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759
[TBL] [Abstract][Full Text] [Related]
11. Proliferation of B cell malignancies in all stages of differentiation upon stimulation in the 'CD40 system'.
Planken EV; Dijkstra NH; Willemze R; Kluin-Nelemans JC
Leukemia; 1996 Mar; 10(3):488-93. PubMed ID: 8642867
[TBL] [Abstract][Full Text] [Related]
12. Expression of TIA-1 and TIA-2 in T cell malignancies and T cell lymphocytosis.
Matutes E; Coelho E; Aguado MJ; Morilla R; Crawford A; Owusu-Ankomah K; Catovsky D
J Clin Pathol; 1996 Feb; 49(2):154-8. PubMed ID: 8655683
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
Cabezudo E; Carrara P; Morilla R; Matutes E
Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919
[TBL] [Abstract][Full Text] [Related]
14. [Immunophenotype of chronic lymphocytic leukemia and prolymphocytic leukemia].
Maruyama S
Nihon Rinsho; 1992 Jun; 50(6):1236-40. PubMed ID: 1518139
[TBL] [Abstract][Full Text] [Related]
15. Assessment of proliferative activity in leukaemic bone marrow using the monoclonal antibody Ki-67.
White DM; Smith AG; Smith JL
J Clin Pathol; 1994 Mar; 47(3):209-13. PubMed ID: 8163690
[TBL] [Abstract][Full Text] [Related]
16. Levels of expression of CD19 and CD20 in chronic B cell leukaemias.
Ginaldi L; De Martinis M; Matutes E; Farahat N; Morilla R; Catovsky D
J Clin Pathol; 1998 May; 51(5):364-9. PubMed ID: 9708202
[TBL] [Abstract][Full Text] [Related]
17. Proliferation in non-Hodgkin's lymphomas as determined by immunohistochemical double staining for Ki-67.
Tominaga K; Yamaguchi Y; Nozawa Y; Abe M; Wakasa H
Hematol Oncol; 1992; 10(3-4):163-9. PubMed ID: 1398512
[TBL] [Abstract][Full Text] [Related]
18. Screening for mutations of Bcl10 in leukaemia.
Grimwade D; Du MQ; Langabeer S; Rogers J; Solomon E
Br J Haematol; 2000 Jun; 109(3):611-5. PubMed ID: 10886211
[TBL] [Abstract][Full Text] [Related]
19. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD; Srivastava A; Srivastava BI
Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
